Biote Corp. - Class A Common Stock BTMD 深 沪
已收盘 10-10 16:00:00 美东时间
2.77
-0.090
-3.15%
华盛通- 最 高2.86
- 今 开2.84
- 成交量 16.37万股
- 最 低 2.7102
- 昨 收 2.86
- 总市值 9161.30万
- 52周最高 6.98
- 市盈率 静 30.08
- 换手率 0.00%
- 52周最低 2.7102
- 委 比 59.20%
- 总股本 3307.33万
- 历史最高 12.08
- 量 比 1.61
- 振 幅 5.24%
- 历史最低 2.7102
- 每 手 1
- 风险率 1.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biote shares are trading lower after the company reported mixed Q2 financial results and cut its FY25 sales guidance below estimates.
Biote shares are trading lower after the company reported mixed Q2 financial re...
08-07 05:33
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Biote Director Steven J. Heyer Resigns
biote ( ($BTMD) ) just unveiled an update. On June 2, 2025, Steven J. Heyer res...
06-05 20:46
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 durin...
05-28 05:06
Earnings Scheduled For May 7, 2025
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Shares of Meta Platforms, Inc. (NASDAQ:META) rose sharply in pre-market trading...
05-01 17:17
Biote Reduces Marc Beer’s Salary Amid Transition
biote ( ($BTMD) ) has provided an update. On April 1, 2025, Marc Beer, Executiv...
04-25 04:54
Biote announces purchase of shares by directors and CEO
biote (NASDAQ:BTMD) said on Tuesday that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of the company's common stock, acquiring an aggrega...
03-19 05:47
美股大行评级 | 花旗：首予BioNTech SE(BNTX)"买入"评级，目标价145美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107226114384474112.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Zevra Therapeutics(ZVRA)"买入"评级，目标价从23美元升至25美元</p> <p>• Benchmark：维持E W Scripps(SSP)"买入"评级，目
03-14 09:45
Biote Sees FY25 Revenue $202M-$208M Vs $227.18M Est.; Adj. EBITDA $59M-$64M
The Company expects the following for fiscal 2025:($ in millions)2025 Guidance Ranges Revenue$202-$208Adjusted EBITDA2$59-642025 Procedure revenue is expected to increase approximately 2-4% from 2024.2025
03-13 22:48
